Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis

British Journal of Haematology

Volumn 115, Issue 2, 2001, Pages 451-459

  Joseph, Joanne E ^a,b   Harrison, Paul ^a   Mackie, Ian J ^a   Isenberg, David A ^a   Machin, Samuel J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Antiphospholipid syndrome; Platelet activation markers; Platelet leucocyte complexes; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

CD63 ANTIGEN; LIPOCORTIN 5; PADGEM PROTEIN; PHOSPHOLIPID ANTIBODY;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; IN VIVO STUDY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE ACTIVATION;

ADULT; AGED; ANNEXIN A5; ANTIPHOSPHOLIPID SYNDROME; ARTHRITIS, RHEUMATOID; ASPIRIN; BLOOD PLATELETS; CELL AGGREGATION; CELL DEGRANULATION; FEMALE; HUMANS; LEUKOCYTES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PLATELET COUNT; PROTEIN-TYROSINE-PHOSPHATASE; THROMBOSIS; WARFARIN;

EID: 0035726226     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.03101.x     Document Type: Article

References (42)

1. The pathogenesis of the antiphospholipid syndrome: A hypothesis based on parallelisms with heparin-induced thrombocytopenia
2. The 'primary' antipho-spholipid syndrome: Major clincial and serological features
3. A platelet alpha-granule protein that is associated with the plasma membrane after activation: Characterisation and subcellular localisation of platelet-activation dependent granule-external membrane protein
4. Changes in membrane phospholipid distribution during platelet activation
5. Flow cytometry reveals activated GP IIb-IIIa complexes on platelets from patients undergoing thrombolytic therapy after acute myocardial infarction
6. Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party of the BCSH Haemostasis and Thrombosis Task Force
7. A new flow cytometry method of platelet-derived microvesicle quantitation in plasma
8. Characterization of GMP-140 (P-selectin) as a circulating plasma protein
9. Thrombogenic mechanisms of antiphospholipid antibodies
10. Flow cytometric detection of circulating activated platelets in primary antiphospholipid syndrome. Correlation with thrombocytopenia and anticardiolipin antibodies
11. Anti-beta2 glycoprotein I. antibodies and platelet activation in patients with antiphospholipid antibodies: Association with increased excretion of platelet-derived thromboxane urinary metabolites
12. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease
13. Platelet-derived micro-vesicles in patients with antiphospholipid antibodies
14. Syndrome of the black swan
15. Evaluation of the anticardiolipin test: Report of an international workshop held 4 April 1986
16. Platelet activation and turnover in the primary antipho-spholipid syndrome
17. A sensitive flow cytometric assay for circulating platelet-leucocyte aggregates
18. Leukocyte interactions mediated by selectins
19. Increased levels of b2 glycoprotein-I antigen and b2 glycoprotein-I binding antibodies are associated with a history of thromboem-bolic complications in patients with SLE and primary antipho-spholipid syndrome
20. Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation
21. Activation during preparation of therapeutic platelets affects deterioration during storage: A comparative flow cytometric study of different production methods
22. In vivo tracking of platelets: Circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function
23. Studies with a monoclonal antibody against activated platelets. Evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation
24. The protein CD63 is in platelet dense granules, is deficient in a patient with Hermansky-Pudlak syndrome, and appears identical to granulophysin
25. The role of platelet microparticles in hemostasis
26. Pathogenesis and treatment of the antipho-spholipid antibody syndrome
27. Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids. A 'lupus procoagulant' phenomenon
28. Dynamics of leukocyte-platelet adhesion in whole blood
29. Activated and unactivated platelet adhesion to monocytes and neutrophils
30. Neutrophil but not monocyte activation inhibits P-selectin mediated platelet adhesion
31. The taipan snake venom time: A new test for lupus anticoagulant
32. In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major
33. Antiphospholipid antibodies and thrombotic predisposition. Underlying pathogenetic mechanisms
34. Changes in the platelet membrane glycoprotein IIb. IIIa complex during platelet activation
35. Detection of activated platelets in whole blood using activation- dependent monoclonal antibodies and flow cytometry
36. Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion
37. Detection of cerebral microemboli in APS - Introducing a novel investigation method and implications of analogies with carotid artery disease
38. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation
39. Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidyl-serine exposure in the procoagulant response of activated platelets
40. Antiphospholipid antibodies and thrombosis. A consequence, coincidence, or cause?
41. Platelet antibody binding and spontaneous aggregation in 21 lupus anticoagulant patients
42. Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis